Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.40 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HTR7 | P34969 | 3/20 | 0.35 |
| ▸ | ESRRA | P11474 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12177017 | 0.80 | KDM4E (0.64) | KDM4EPOLBCTDSP1HPGDDYRK1A | |
| SCHEMBL28024588 | 0.80 | HTR6 (0.51) | KDM4EHPGDNPSR1L3MBTL1ALDH1A1 | |
| SCHEMBL1883807 | 0.75 | KDM4E (0.58) | KDM4EPOLBCTDSP1HPGDDYRK1A | |
| SCHEMBL10325497 | 0.75 | KDM4E (0.51) | KDM4EPOLBCTDSP1HPGDDYRK1A | |
| SCHEMBL27747002 | 0.75 | HTR6 (0.65) | L3MBTL1HTR7 | |
| SCHEMBL13335089 | 0.74 | KDM4E (0.57) | KDM4EPOLBCTDSP1HPGDDYRK1A | |
| SCHEMBL13335069 | 0.74 | KDM4E (0.57) | KDM4EPOLBCTDSP1HPGDDYRK1A | |
| SCHEMBL7441180 | 0.74 | SIRT2 (0.53) | POLBPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL13335116 | 0.73 | KDM4E (0.55) | KDM4EPOLBCTDSP1HPGDDYRK1A | |
| SCHEMBL13335074 | 0.71 | KDM4E (0.54) | KDM4EPOLBCTDSP1HPGDDYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9382206-B2 | Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-05 | — | — | US | disclosed |
| EP-2628729-A1 | AROMATIC HETEROCYCLIC DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2013-08-21 | — | — | EP | disclosed |
| US-20120273766-A1 | AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-01 | — | — | US | disclosed |
| US-20120181524-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120181524-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | AOC3, NPR3, NR0B1 | KDM4E 3595/4885POLB 1070/4885CTDSP1 3864/4885 |
| US-20120273766-A1 | AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | DDC, ODC1, TYR | KDM4E 1308/4885POLB 1681/4885CTDSP1 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.